Company Filing History:
Years Active: 2011
Title: The Innovations of Robert Whittock
Introduction
Robert Whittock is a notable inventor based in Leicestershire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new medicaments. His work focuses on innovative compounds that can aid in the treatment of respiratory diseases.
Latest Patents
Whittock holds a patent for a compound titled "Pharmaceutical salts of N-[2-(diethylamino)ethyl]-N-(2-{[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]amino}ethyl)-3-[2-(1-napthyl)ethoxy]propanamide." This patent describes a pharmaceutically acceptable salt of the compound, excluding the dihydrobromide or dihydrochloride salt. The compound is intended for use as a medicament, particularly in the treatment of respiratory diseases such as asthma or COPD. Whittock has 1 patent to his name.
Career Highlights
Whittock is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role involves research and development of innovative pharmaceutical solutions. His expertise in medicinal chemistry has been instrumental in advancing the company's product offerings.
Collaborations
Whittock collaborates with Jane Withnall, a fellow researcher at AstraZeneca AB. Together, they work on various projects aimed at improving therapeutic options for patients with respiratory conditions.
Conclusion
Robert Whittock's contributions to pharmaceutical innovation highlight the importance of research in developing effective treatments for respiratory diseases. His work continues to impact the field positively, showcasing the potential of innovative compounds in medicine.